Read retired as Pfizer’s executive chairman on Dec. 31, 2019, completing an extraordinary, 41-year career with the global pharmaceutical company. During his nine years as CEO and chairman, Ian brought a consistent focus on culture, talent, growth and value creation, as Pfizer transformed to become a stronger and more stable enterprise. Read received his B.Sc. in chemical engineering from London University Imperial College. He earned his Chartered Accountants certification from the Institute of Chartered Accountants of England and Wales.